XML 48 R32.htm IDEA: XBRL DOCUMENT v3.25.0.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 28, 2024
Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents and Investments
Cash, cash equivalents, and investments are reflected in the Consolidated Balance Sheets and were as follows:
December 28, 2024December 30, 2023
Cash and cash equivalentsShort-term investmentsOther AssetsCash and cash equivalentsShort-term investmentsOther Assets
Debt securities$— $2.0 $11.9 $— $1.2 $12.3 
Equity investments— 4.4 7.2 — 4.3 7.0 
Cash and money market accounts22.5 — — 28.9 — — 
Total$22.5 $6.4 $19.1 $28.9 $5.6 $19.3 

The following table summarizes the amortized cost basis of the debt securities:
December 28, 2024December 30, 2023
Amortized cost basis of debt securities$14.1 $13.8 
Schedule of Allowance for Doubtful Accounts The following table summarizes the change in the allowance for doubtful accounts:
Balance at beginning of periodCurrent provision and adjustmentsAmounts written offRecoveries and otherAcquisition and divestiture of businessesBalance at end of period
Year ended December 28, 2024$3.5 $(0.7)$(0.9)$0.1 $— $2.0 
Year ended December 30, 2023$3.2 $0.3 $(0.5)$0.0 $0.4 $3.5 
Year ended December 31, 2022$2.8 $1.7 $(1.0)$0.2 $(0.5)$3.2 
Schedule of Inventories Included in Consolidated Balance Sheet Inventories included in the Consolidated Balance Sheets consisted of the following:
December 28, 2024December 30, 2023
Finished products, net$122.4 $112.9 
Materials and work in process, net119.5 128.2 
LIFO allowance(47.5)(44.5)
Total inventories, net$194.3 $196.6 
Inventory valued by the LIFO costing method91 %91 %
Schedule of Property, Plant and Equipment
Total depreciation expense was as follows:
202420232022
Depreciation expense$76.9 $64.7 $53.3 
Schedule of Accounts Payable and Accrued Liabilities
Accounts payable and accrued expenses are reflected in the Consolidated Balance Sheets and were as follows:
December 28, 2024December 30, 2023
Trade accounts payable$190.4 $193.7 
Compensation50.8 65.1 
Profit sharing and retirement9.1 10.5 
Accrued marketing programs25.4 31.4 
Accrued freight11.0 12.9 
Customer deposits42.1 35.6 
Other accrued expenses62.4 69.4 
Total accounts payable and accrued expenses$391.2 $418.7 
Schedule of Product Warranties
Activity associated with warranty obligations was as follows:
202420232022
Balance at beginning of period$18.0 $14.8 $16.0 
Accruals related to acquisitions— 3.5 — 
Accruals for warranties issued13.0 11.6 9.3 
Settlements and other(13.6)(11.9)(10.5)
Balance at end of period$17.5 $18.0 $14.8 
The following table summarizes when these estimated settlements are expected to be paid:
December 28, 2024December 30, 2023
Current - in the next twelve months$6.6 $6.0 
Long-term - beyond one year10.9 12.0 
Total$17.5 $18.0 
Schedule of Research and Development Costs The amounts charged against income and recorded in "Selling and administrative expenses" on the Consolidated Statements of Comprehensive Income were as follows:
202420232022
Research and development costs$53.6 $47.2 $47.8 
Schedule of Freight Expense
Freight expense on shipments to customers was recorded in "Selling and administrative expenses" on the Consolidated Statements of Comprehensive Income as follows:
202420232022
Freight expense$135.0 $137.8 $142.0 
Schedule of Earnings Per Share, Basic and Diluted
The following table reconciles the numerators and denominators used in the calculation of basic and diluted earnings per share ("EPS"):
202420232022
Numerator:   
Numerator for both basic and diluted EPS attributable to HNI Corporation net income$139.5 $49.2 $123.9 
Denominators:   
Denominator for basic EPS weighted-average common shares outstanding47.4 44.5 41.7 
Potentially dilutive shares from stock-based compensation plans1.1 0.8 0.5 
Denominator for diluted EPS48.5 45.4 42.2 
Earnings per share – basic$2.95 $1.11 $2.97 
Earnings per share – diluted$2.88 $1.09 $2.94 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The weighted-average common stock equivalents presented above do not include the effect of the common stock equivalents in the table below because their inclusion would be anti-dilutive:
202420232022
Common stock equivalents excluded because their inclusion would be anti-dilutive0.4 2.1 2.0 
Schedule of Insurance Reserves The general, auto, product, and workers’ compensation liabilities are managed using a wholly-owned insurance captive and the related liabilities are included in the Consolidated Balance Sheets as follows:
December 28, 2024December 30, 2023
Current - "Accounts payable and accrued expenses"$5.4 $5.9 
Non-current - "Other Long-Term Liabilities"18.0 18.8 
Total general, auto, product, and workers’ compensation liabilities$23.4 $24.8